Multiple Sclerosis/*drug therapy | Jeroen Van Schependomhttps://jeroenvanschependom.be/tag/multiple-sclerosis/drug-therapy/Multiple Sclerosis/*drug therapyWowchemy (https://wowchemy.com)en-ushttps://jeroenvanschependom.be/media/icon_hu898bad6a947579ff95e6bfac4d9757a2_264109_512x512_fill_lanczos_center_3.pngMultiple Sclerosis/*drug therapyhttps://jeroenvanschependom.be/tag/multiple-sclerosis/drug-therapy/Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment.https://jeroenvanschependom.be/publication/de-troyer-clinical-2024/Mon, 01 Jul 2024 00:00:00 +0000https://jeroenvanschependom.be/publication/de-troyer-clinical-2024/Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.https://jeroenvanschependom.be/publication/van-schependom-assessing-2016/Tue, 01 Mar 2016 00:00:00 +0000https://jeroenvanschependom.be/publication/van-schependom-assessing-2016/